PYC Physiomics Plc

0.0055USD0.4150 GBp · LSE0.00%Mkt Cap: 2.55M USDP/E: —

Physiomics Plc engages in the provision of consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the …

Key Statistics

Company
Market Cap2.55M USD
Enterprise Value1.93M USD
Revenue (TTM)1.39M USD
Gross Profit-857.98K USD
Net Income (TTM)-917.89K USD
Revenue/Share0.0040 USD
Last Price0.0055 USD
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees11
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINGB00BDR6W943
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA-2.16
EV/Revenue1.39
P/S1.84
P/B4.15
EPS (TTM)0.00 USD
EPS (Forward)-0.45 USD
52W Range
0.003330% of range0.0105
52W High0.0105 USD
52W Low0.0033 USD
Profitability
Gross Margin-61.75%
Oper. Margin-64.96%
EBITDA Margin-64.12%
Profit Margin-74.06%
ROE-133.03%
ROA-88.39%
ROIC—
ROCE-131.16%
Growth
Revenue Growth9.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-741.19K USD
CapEx (TTM)5.83K USD
FCF Margin-26.72%
FCF Yield-14.54%
Net Debt-551.28K USD
Net Debt/EBITDA0.62
Net Debt/FCF—
Balance Sheet
Debt/Equity—
Current Ratio2.88
Quick Ratio2.27
Book Value/Sh0.0013 USD
Cash/Share0.0013 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateDec 19, 2016
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.467.21M
Float304.24M
Insiders24.96%
Institutions2.23%
Technical
SMA 500.0064 (-14.3%)
SMA 2000.0066 (-17.5%)
Beta1.09
S&P 52W Chg12.08%
Avg Vol (30d)2.03M
Avg Vol (10d)1.22M
Technical Indicators
RSI (14)23.6
MACD-0.0173
MACD Signal-0.0185
MACD Hist.+0.0013
BB Upper0.0064 USD
BB Middle0.0057 USD
BB Lower0.0051 USD
BB Width22.41%
ATR (14)0.0005 USD
Vol Ratio (20d)0.83x

About Physiomics (LON: PYC)

›

Physiomics (LON: PYC) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 11 employees.

The shares were at 0.4150 GBp on 19 November 2026, down 1.2% over 52 weeks. Its 52-week range is 0.2530 GBp to 0.8000 GBp: the price is 48.1% below the high and 64.0% above the low.

Its market capitalisation is 1.94M GBP.

Physiomics reports return on equity of -133.0%, an operating margin of -65.0% and revenue up 9.8% year over year.

It holds more cash than debt, a net cash position of 418.63K GBP. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.